Sandoz Inc. recently announced that the FDA has accepted its Biologics License Application for filgrastim, which was filed under the new biosimilar pathway created in the Biologics Price Competition and Innovation Act of 2009. The company filed ... Orthopedics Today, 2 days ago
U.S. Paves Way for Copycat Version of Neupogen (Filgrastim) - General Medicine eJournal, 5 days ago
Sandoz application for biosimilar Neupogen accepted by US FDA25-07-2014 - Pharma Letter, 5 days ago
BANGALORE : Infosys CFO Rajiv Bansal has been appointed as the chairman of Infosys Lodestone, a wholly-owned subsidiary of the $8.2 billion IT firm that was acquired for $350 million in 2012. Infosys Lodestone is a Switzerland -based global ...4 Traders, 4 weeks ago Bansal made Infosys Lodestone chairman Times of India, 1 month ago
details Date: June 8 10, 2014 Time: 9 a.m. to 5 p.m. Venue: Gaylord National Convention Center, Washington, DC Speaker(s): Hardy Düsterwald, General Manager, BPMICoE, Telstra with co-presenter Susanto Kumar De, Program Manager, Infosys and ...Infosys, 2 months ago
on your WebpageAdd Widget >Get your members hooked!